Paper Type |
:: |
Research Paper |
Title |
:: |
The role of the clinical pharmacist in the management of type 2 diabetes: current insights and future direction |
Country |
:: |
India |
Authors |
:: |
T. Arokiasamy |
Page No. |
:: |
01-04 |
The role of pharmacists in diabetes management, including patient identification, assessment, education, referral, and monitoring, is described. Pharmacists can help identify patients with diabetes through screening and should target patients at high risk, people with a family history of the disease, and women with a history of gestational diabetes or who delivered a baby weighing more than nine pounds. Patient education should be provided immediately after diagnosis, at a second stage at which time a patient assessment can be performed, and at a third stage during which patients can receive continuing education to reinforce concepts and a motivational boost..........
Keywords : Pharmacy, interventions, outcomes, benefits, glycemic control, cost – effectiveness.
[1]. American Diabetes Association Standards of medical care in diabetes - 2013. Diabetes Care. 2013;36(Suppl 1):S11–S66.
[2]. Pinhas-Hamiel O, Zeitler P. The global spread of type 2 diabetes mellitus in children and adolescent. J Pediatr. 2005;146(5):693–700.
[3]. American Diabetes Association Type 2 diabetes in children and adolescents. Diabetes Care. 2000;23 (3):381–389.
[4]. International Diabetes Federation IDF Diabetes Atlas. Seventh Edition. 2015. Available from: www.diabetesatlas.org. Accessed October 28, 2016.
[5]. World Health Organization Obesity and overweight. Fact sheet [updated June 2016] [Accessed October 28, 2016]. Available from: http://www.who.int/media centre/factsheets/fs311/en/Accessed October 28,2016.
Paper Type |
:: |
Research Paper |
Title |
:: |
Prevalence and Risk Factors Associated with Type 2 Diabetes in Elderly Patients |
Country |
:: |
|
Authors |
:: |
xxx |
Page No. |
:: |
05-08 |
Diabetes mellitus (DM), also termed as "sugar," is a chronic, noncommunicable disease (NCD) which has emerged as one of the leading global health problem associated with the pancreas in the production of insulin leading to hyperglycemia . Type 2 diabetes mellitus is associated with a combination of resistance to insulin action and inadequate compensatory insulin secretory response.......
[1].
C. Bommer, V. Sagalova, E. Heesemann et al., "Global economic burden of diabetes in adults: projections from 2015
[2].
to 2030," Diabetes Care, vol. 41, no. 5, pp. 963–970, 2018.View at: Publisher Site | Google Scholar
[3].
F. S. Chiwanga, M. A. Njelekela, M. B. Diamond et al., "Urban and rural prevalence of diabetes and pre-diabetes and
[4].
risk factors associated with diabetes in Tanzania and Uganda," Global Health Action, vol. 9, no. 1, article 31440, 2016.View at: Publisher Site | Google Scholar
[5].
R. Dehnavieh, A. Haghdoost, A. Khosravi et al., "The District Health Information System (DHIS2): A literature review
Paper Type |
:: |
Research Paper |
Title |
:: |
Formulation and Evaluation of Transdermal Patch Containing Cyproheptadine |
Country |
:: |
India |
Authors |
:: |
G.Rohitha, Swarupa Arvapalli, J.V.C Sharma |
Page No. |
:: |
09-23 |
The skin can be used as the site for drug administration for continuous transdermal drug infusion into the systemic circulation. For the continuous diffusion penetration of the drugs through the intact skin surface membrane-moderated systems, matrix dispersion type systems, adhesive diffusion controlled systems and micro reservoir systems have been developed. Various penetration enhancers are used for the drug diffusion through skin. In matrix dispersion type systems, the drug is dispersed in the solvent along with the polymers and solvent allowed to evaporate forming a homogeneous drug-polymer matrix........
Keywords: Cyproheptadine,Transdermal drug delivery, Diffusion, Penetration enhancers, Higuchi release.
[1].
Chien Y.W. "Novel Drug Delivery Systems", 2nd Edition, Drugs And Pharmaceutical Sciences, Volume-50, Marcel Dekker, Inc.
[2].
Finnin B C, Morgan T M, Trasndermal penetration. J Pharm Sci. Oct 1999;88 (10):955-958.
[3].
Allen L V, Popovich N G, Ansel H C, Ansel's Pharmaceutical Dosage Forms and Drug Delivery Sysstems, 8th Edition, Lippincott Williams &wilkins, 2005:298- 315.
[4].
Barry B. Transdermal Drug Delivery. In Ed: Aulton M E, Pharmaceutics: The Science of Dosage Form Design, Churchill Livingston. 2002:499-533
[5].
Cleary G W, Transdermal controlled release systems. Medical Applications of Controlled Release. 1:203-251.
Paper Type |
:: |
Research Paper |
Title |
:: |
Molecular Dockingon The Metabolites in Rhoeo discolor as Antibacterial Agent |
Country |
:: |
Indonesia |
Authors |
:: |
Vanesha Yohana, Clarissa Christy, Emilia Haryanto, Savira Yasim, Wulan Safitri, Andhi Fahrurroji |
Page No. |
:: |
24-30 |
Chronic wounds tend to be suffered by people with diabetes mellitus and paralysis, which causes decubitus ulcers. The older the age, low the immunity and the risk of getting infected with the wound become higher. Staphylococcus aureus, Pseudomonas aeruginosa, and methicillin-resistant Staphylococcus aureus have been reported as the common causes in this case. This has led to reduced quality of life and depression in some patients; even post-amputation surgery sites of the part still have the potential complication of infection. Rhoeo discolor, occurs in many tropical countries that are found to have antibacterial.......
Keywords: Molecular docking; Methicillin-resistant Staphylococcus aureus; Rhoeo discolor;Pseudomonas aeruginosa; Staphylococcus aureus.
[1]. Gould L, Abadir P, Brem H, Carter M, Conner-Kerr T, Davidson J, et al. Chronic wound repair and healing in older adults: Current status and future research. Wound Repair and Regeneration. 2015 Jan 1;23(1):1–13.
[2]. Berbudi A, Rahmadika N, Tjahjadi AI, Ruslami R. Type 2 Diabetes and its Impact on the Immune System. Curr Diabetes Rev. 2020 Oct 28;16(5):442–9.
[3]. Garoy EY, Gebreab YB, Achila OO, Tekeste DG, Kesete R, Ghirmay R, et al. Methicillin-Resistant Staphylococcus aureus (MRSA): Prevalence and Antimicrobial Sensitivity Pattern among Patients - A Multicenter Study in Asmara, Eritrea. Canadian Journal of Infectious Diseases and Medical Microbiology. 2019;2019.
[4]. Kadam S, Nadkarni S, Lele J, Sakhalkar S, Mokashi P, Kaushik KS. Bioengineered Platforms for Chronic Wound Infection Studies: How Can We Make Them More Human-Relevant? Front BioengBiotechnol. 2019 Dec 13;7(418):1–15.
[5]. Fino P, Taranto G di, Pierro A, Kacjulite J, Codolini L, Onesti MG, et al. Depression risk among patients with chronic wounds. Eur Rev Med Pharmacol Sci [Internet]. 2019;23:4310–2. Available from: www.minddisorders.com/A-Br/Beck-De-
Paper Type |
:: |
Research Paper |
Title |
:: |
Public's Perception Knowledge, Attitude and Behaviour on Antibiotic Resistance – A survey in Bangalore City, India |
Country |
:: |
India |
Authors |
:: |
Aniket Rao, Diya Kamdar, Gabriela Fernandes |
Page No. |
:: |
31-37 |
This study was designed to assess the general public's perception, knowledge, attitude and behaviour on antibiotic resistance in a Bangalore, a metropolitan city in the south of India. It also tries to decipher whether the level of education and the professional status of an individual has a positive association with the level of knowledge on antibiotic resistance.Of all the participants who participated in the study, around 95.5% of the surveyed population received a university education. About 81.6% of the participants had knowledge about antibiotic resistance and 82.2% of them believed that many bacterial infections.......
Key-words: Antibiotic resistance, Drugs, Internal Medicine
[1]. Alós JI. Resistencia bacteriana a los antibióticos: una crisis global [Antibiotic resistance: A global crisis]. Enferm Infecc Microbiol Clin. 2015 Dec;33(10):692-9. Spanish. doi: 10.1016/j.eimc.2014.10.004. Epub 2014 Dec 1. PMID: 25475657.
[2]. Dever LA, Dermody TS. Mechanisms of bacterial resistance to antibiotics. Arch Intern Med. 1991 May;151(5):886-95. PMID: 2025137.
[3]. Lamberte LE, van Schaik W. Antibiotic resistance in the commensal human gut microbiota. Curr Opin Microbiol. 2022 Aug;68:102150. doi: 10.1016/j.mib.2022.102150. Epub 2022 Apr 28. PMID: 35490629.
[4].
Chinemerem Nwobodo D, Ugwu MC, Oliseloke Anie C, Al-Ouqaili MTS, Chinedu Ikem J, Victor Chigozie U, Saki M. Antibiotic resistance: The challenges and some emerging strategies for tackling a global menace. J Clin Lab Anal. 2022 Sep; 10.10, 36(9):e24655.
[5].
Tarín-Pelló A, Suay-García B, Pérez-Gracia MT. Antibiotic resistant bacteria: current situation and treatment options to accelerate the development of a new antimicrobial arsenal. Expert Rev Anti Infect Ther. 2022 Aug; 10.1080/1478721, 20(8):1095-1108.
©All Rights Reserved | Design by iosrphr